The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers. (Q53189724)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Yen-Wen Wu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Yi-Chih Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Kai-Yuan Tzen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ruoh-Fang Yen

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Hsian-Li Kao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Chi-Lun Huang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ming-Fong Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Lian-Yu Lin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Yen-Hung Lin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Hung-Ju Lin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Yu-Chiao Chi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Por-Jau Huang

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

23 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

number of pages

9

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

399-407

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22109668%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-011-1994-7

17 January 2020

exact match

0 references

cites work

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Inflammation as a possible link between coronary and carotid plaque instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Vascular inflammation stratified by C-reactive protein and low-density lipoprotein cholesterol levels: analysis with 18F-FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

(18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Prolonged high-fat feeding enhances aortic 18F-FDG and 99mTc-annexin A5 uptake in apolipoprotein E-deficient and wild-type C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Reversal of vascular 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Evidence for lower variability of coronary artery calcium mineral mass measurements by multi-detector computed tomography in a community-based cohort--consequences for progression studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Statistical methods for assessing agreement between two methods of clinical measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Coronary calcium does not accurately predict near-term future coronary events in high-risk adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun N-terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Effect of atorvastatin and fenofibric acid on adipokine release from visceral and subcutaneous adipose tissue of patients with mixed dyslipidemia and normolipidemic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

The activin A-follistatin system: potent regulator of human extracellular matrix mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Circulating concentrations of follistatin-like 1 in healthy individuals and patients with acute coronary syndrome as assessed by an immunoluminometric sandwich assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-011-1994-7

Arterial foci of F-18 fluorodeoxyglucose are associated with an enhanced risk of subsequent ischemic stroke in cancer patients: a case-control pilot study

21 January 2018

1 reference

12 December 2020

Serum adipocyte fatty acid-binding protein is associated independently with vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography

1 reference

12 December 2020

Association of adiponectin, resistin, and vascular inflammation: analysis with 18F-fluorodeoxyglucose positron emission tomography

1 reference

12 December 2020

In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients

1 reference

12 December 2020

Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques.

1 reference

12 December 2020

Characterization of plaques using 18F-FDG PET/CT in patients with carotid atherosclerosis and correlation with matrix metalloproteinase-1.

1 reference

12 December 2020